Sanofi
SNY
42,98 €
Share price
-2.28%
Change (1 day)
-0.19%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Earnings for Sanofi (SNY)
Earnings in 2025 (TTM): €8.02 Billion
According to Sanofi's latest financial reports the company's current earnings are €47.43 Billion. In 2024 the company made an earning of €7.03 Billion a decrease over its 2023 earnings that were of €7.75 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Sanofi from 2005 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | €8.02 B | 14.05% |
| 2024 | €7.03 B | -9.36% |
| 2023 | €7.75 B | -28.79% |
| 2022 | €10.89 B | 32.64% |
| 2021 | €8.21 B | |
| 2019 | €3.26 B | -32.52% |
| 2018 | €4.84 B | -18.66% |
| 2017 | €5.95 B | -9.88% |
| 2016 | €6.60 B | 17.04% |
| 2015 | €5.64 B | -10.97% |
| 2014 | €6.33 B | 21.68% |
| 2013 | €5.20 B | -19.93% |
| 2012 | €6.50 B | 10.76% |
| 2011 | €5.87 B | -3.21% |
| 2010 | €6.06 B | -5.07% |
| 2009 | €6.39 B | |
| 2005 | €5.06 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Merck MRK | €18.56 B | 144.29% | 🇺🇸 USA |
 Pfizer PFE | €8.94 B | 17.77% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | €5.28 B | -30.44% | 🇺🇸 USA |
 Novartis NVS | €12.91 B | 69.90% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | €4.68 B | -38.37% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | €0.39 B | -94.83% | 🇮🇱 Israel |
 Johnson & Johnson JNJ | €23.71 B | 212.15% | 🇺🇸 USA |
 Eli Lilly LLY | €11.76 B | 54.89% | 🇺🇸 USA |
 Novo Nordisk NVO | €17.43 B | 129.44% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | €6.36 B | -16.23% | 🇺🇸 USA |